Dong Zheng1, Yong Yu2, Minghui Li2, Grace Wang3, Ruizhen Chen2, Guo-Chang Fan4, Claudio Martin5, Sidong Xiong6, Tianqing Peng1. 1. Jiangsu Key Laboratory of Infection and Immunity, Institutes for Biology and Medical Sciences, Soochow University, Suzhou Lawson Health Research Institute Department of Medicine Department of Pathology, University of Western Ontario, London, Canada. 2. Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China. 3. Department of Pathology, University of Western Ontario, London, Canada. 4. Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Ohio. 5. Lawson Health Research Institute Department of Medicine. 6. Jiangsu Key Laboratory of Infection and Immunity, Institutes for Biology and Medical Sciences, Soochow University, Suzhou.
Abstract
BACKGROUND: MicroRNAs (miRs) are a class of short RNA molecules, which negatively regulate gene expression. The levels of circulating miR-15 family members are elevated in septic patients and may be associated with septic death. This study investigated whether inhibition of miR-195, a member of the miR-15 family, provided beneficial effects in sepsis. METHODS AND RESULTS: Sepsis was induced by injection of feces into the peritoneum in mice. miR-195 was upregulated in the lung and liver of septic mice. Silencing of miR-195 increased the protein levels of BCL-2, Sirt1, and Pim-1; prevented apoptosis; reduced liver and lung injury; and improved the survival in septic mice. Silencing of miR-195 provided similar protection in lipopolysaccharide-induced endotoxemic mice. In endothelial cells, upregulation of miR-195 induced apoptosis, and inhibition of miR-195 prevented lipopolysaccharide-induced apoptosis. miR-195 repressed expression of its protein targets, BCL-2, Sirt1, and Pim-1. Furthermore, overexpression of Pim-1 prevented apoptosis induced by lipopolysaccharide and miR-195 mimic. Inhibition of Pim-1 attenuated the protective effects of miR-195 silencing in septic mice. CONCLUSIONS: Silencing of miR-195 reduced multiple-organ injury and improved the survival in sepsis, and the protective effects of miR-195 inhibition were associated with upregulation of Bcl-2, Sirt1, and Pim-1. Thus, inhibition of miR-195 may represent a new therapeutic approach for sepsis.
BACKGROUND: MicroRNAs (miRs) are a class of short RNA molecules, which negatively regulate gene expression. The levels of circulating miR-15 family members are elevated in septic patients and may be associated with septic death. This study investigated whether inhibition of miR-195, a member of the miR-15 family, provided beneficial effects in sepsis. METHODS AND RESULTS:Sepsis was induced by injection of feces into the peritoneum in mice. miR-195 was upregulated in the lung and liver of septic mice. Silencing of miR-195 increased the protein levels of BCL-2, Sirt1, and Pim-1; prevented apoptosis; reduced liver and lung injury; and improved the survival in septic mice. Silencing of miR-195 provided similar protection in lipopolysaccharide-induced endotoxemic mice. In endothelial cells, upregulation of miR-195 induced apoptosis, and inhibition of miR-195 prevented lipopolysaccharide-induced apoptosis. miR-195 repressed expression of its protein targets, BCL-2, Sirt1, and Pim-1. Furthermore, overexpression of Pim-1 prevented apoptosis induced by lipopolysaccharide and miR-195 mimic. Inhibition of Pim-1 attenuated the protective effects of miR-195 silencing in septic mice. CONCLUSIONS: Silencing of miR-195 reduced multiple-organ injury and improved the survival in sepsis, and the protective effects of miR-195 inhibition were associated with upregulation of Bcl-2, Sirt1, and Pim-1. Thus, inhibition of miR-195 may represent a new therapeutic approach for sepsis.
Authors: R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl Journal: J Immunol Date: 2001-06-01 Impact factor: 5.422
Authors: Cláudia Regina Gasque Schoof; Eder Leite da Silva Botelho; Alberto Izzotti; Luciana Dos Reis Vasques Journal: Am J Cancer Res Date: 2012-06-28 Impact factor: 6.166
Authors: Akiko Iwata; R Angelo de Claro; Vicki L Morgan-Stevenson; Joan C Tupper; Barbara R Schwartz; Li Liu; Xiaodong Zhu; Katherine C Jordan; Robert K Winn; John M Harlan Journal: PLoS One Date: 2011-02-24 Impact factor: 3.240
Authors: Elizabeth A Middleton; Jesse W Rowley; Robert A Campbell; Colin K Grissom; Samuel M Brown; Sarah J Beesley; Hansjörg Schwertz; Yasuhiro Kosaka; Bhanu K Manne; Krystin Krauel; Neal D Tolley; Alicia S Eustes; Li Guo; Robert Paine; Estelle S Harris; Guy A Zimmerman; Andrew S Weyrich; Matthew T Rondina Journal: Blood Date: 2019-07-31 Impact factor: 22.113
Authors: He Ma; Xiaohui Wang; Tuanzhu Ha; Ming Gao; Li Liu; Ruitao Wang; Kaijiang Yu; John H Kalbfleisch; Race L Kao; David L Williams; Chuanfu Li Journal: J Infect Dis Date: 2016-09-28 Impact factor: 5.226
Authors: Jeffery Ho; Hung Chan; Sunny H Wong; Maggie H T Wang; Jun Yu; Zhangang Xiao; Xiaodong Liu; Gordon Choi; Czarina C H Leung; Wai T Wong; Zheng Li; Tony Gin; Matthew T V Chan; William K K Wu Journal: Crit Care Date: 2016-11-28 Impact factor: 9.097
Authors: Dana Elena Giza; Enrique Fuentes-Mattei; Marc David Bullock; Stefan Tudor; Matthew Joseph Goblirsch; Muller Fabbri; Florea Lupu; Sai-Ching Jim Yeung; Catalin Vasilescu; George Adrian Calin Journal: Cell Death Differ Date: 2016-10-14 Impact factor: 15.828